DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the SHALBY LIMITED (SHALBY) share price today?

SHALBY LIMITED (SHALBY) is trading at ₹163.99 on the NSE, down 1.50% on the day. Source: DocStoX.

What is the PE ratio of SHALBY LIMITED?

SHALBY LIMITED has a price-to-earnings (PE) ratio of 47.4 in the Healthcare Services sector.

What is the market capitalisation of SHALBY LIMITED?

SHALBY LIMITED has a market capitalisation of approximately ₹1,775 crore.

SHALBY LIMITED

SHALBY·NSE·Healthcare Services

₹163.99▼ -2.50 (-1.50%)

Healthcare Services · Hospitals

A steady, established business

Day₹163.00

₹167.04

52W₹126

₹27526%

Open

₹167.00

High

₹167.04

Low

₹163.00

Prev Close

₹166.49

Volume

50.7K

VWAP

₹164.39

Snapshot

Key fundamentals

Market Cap

₹1,775 Cr

P/E Ratio

47.40Expensive

P/B Ratio

1.87

EPS

₹3.46

Book Value

₹93.10

ROE

3.74%Weak

ROCE

6.00%Weak

Dividend Yield

0.71%

Debt / Equity

0.59Moderate

Face Value

₹10.00

52W High

₹274.70

52W Low

₹125.82

Sector

Healthcare Services

Industry

Hospitals

Avoid

None moatMedium uncertainty

Fair value estimate

₹83

▼ 49.1%downside

Trading at ₹164 — 49% above our estimate

BearFair valueBull

₹71₹83₹96

/100

Business quality — Watch the fundamentals

Growth 25Profitability 3Efficiency 0Valuation 39

Plain English

Our view

A steady, established business
Promoters hold a controlling stake
Weak returns on equity (4%)

Strengths

Promoters hold a controlling stake

Risks

Weak returns on equity (4%)
Fundamental red flags (Piotroski 2/9)

How we got there

Fair value methods

Residual income

4% ROE fading to 13% over ~3 yrs, on ₹93 book

₹83

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹85

Analyst target

No analyst coverage

—

Blended fair value₹83

What the numbers say

Investment thesis

Bull case

Promoters hold a controlling stake

Bear case

Weak returns on equity (4%)
Fundamental red flags (Piotroski 2/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

47.4Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

3.7%Weak

Above 15% is considered healthy for Indian equities

ROCE

6.0%Weak

Above 18% means capital is working hard

Debt/Eq

0.59Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹1,775 Cr

P/B

1.87

EPS

₹3.46

Div Yield

0.71%

What changed

Recent changes

Foreign investors-0.1% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 47.4×

Growth

Steady

+12% rev CAGR

Profitability

Modest

3.7% ROE

Financial health

Comfortable

D/E 0.59

Momentum

N/A

No technicals

Today

Trading activity

Delivery %49.6%

Turnover₹83.31L Cr

Trades1,419

VWAP₹164.39

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+12.3%

+21.5%

10Y

+14.7%

Profit

-19.9%

-3.6%

10Y

-0.3%

EPS

-18.0%

-2.5%

10Y

-2.1%

Profile

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Company has a low return on equity of 4.15% over last 3 years.
Dividend payout has been low at 5.11% of profits over last 3 years

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Foreign investors sold 0.11 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

74%

Promoter

Promoters

74.3%0.00

Public

11.5%-0.21

FII / FPI

4.4%-0.11

DII

0.3%+0.05

Others

9.5%

Total shareholders

51,415-1,080 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter74.33%

FII4.36%

DII0.25%

Public11.52%

Others9.54%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

SHALBY LIMITED valuation & research

Deep-dive tools with DocStoX's fair-value estimate, ratios and peers.

Fair Value Intrinsic Value DCF Valuation Financial Ratios Peers

SHALBY LIMITED peers in Healthcare Services

Other Healthcare Services stocks on the NSE & BSE. See the full Healthcare Services sector list.

SHALBY LIMITED

Key fundamentals

Key statistics

Recent changes

News impact

Overview

Trading activity

Technical signals

Growth (CAGR)

Company information

Cons

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership breakdown

Ownership over time

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Frequently asked questions

SHALBY LIMITED valuation & research

SHALBY LIMITED peers in Healthcare Services

Key statistics

Recent changes

News impact

Trading activity

Technical signals

Growth (CAGR)

Company information

Cons

Ownership breakdown

Ownership over time

Frequently asked questions